Verseon’s scientific journey to highly promising therapeutic candidates for cardiovascular disease appears in European Journal of Medicinal Chemistry
December 14, 2022
Field Medical and CardioNXT Collaborate to Deliver Novel Integration of Focal Pulsed Field Ablation And 3D Mapping & Navigation For Treatment of Cardiac Arrhythmias
December 14, 2022 —  Field Medical, Inc. and CardioNXT, Inc. announce a strategic collaboration to provide the first-of…
Read More
Corindus, A Siemens Healthineers Company, has officially rebranded as Siemens Healthineers
December 14, 2022
Corindus, A Siemens Healthineers Company, Is Now Siemens Healthineers Endovascular Robotics
December 14, 2022 — Corindus, A Siemens Healthineers Company, has been rebranded to Siemens Healthineers Endovascular…
Read More
Series to feature leading experts discussing the current and future trends in the carotid treatment market
December 13, 2022
InspireMD Announces “12 Days of Carotid Stenting” Video Series Featuring Fireside Chats with Top Multidisciplinary Vascular Specialists
December 13, 2022 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention…
Read More
Edwards Lifesciences Corporation announced that one-year results on patients treated in the single-arm, prospective, global, multi-center TRISCEND study of the company's EVOQUE transcatheter tricuspid valve replacement system demonstrated favorable safety, efficacy and quality-of-life outcomes.
December 13, 2022
Edwards Announces One-year Data on Transfemoral Transcatheter Tricuspid Valve Replacement
December 13, 2022 — Edwards Lifesciences Corporation announced that one-year results on patients treated in the single-…
Read More
Image courtesy of Intermountain Healthcare
December 13, 2022
Study Finds Patients Without Standard Modifiable Heart Risk Factors Are Common and More Likely to Fare Better After Heart Attack Than Patients with Known Factors
December 13, 2022 — A new study by researchers at Intermountain Healthcare in Salt Lake City finds that patients…
Read More
The global pacemakers market is set to grow at a compound annual growth rate (CAGR) of 5.4% between 2022 and 2025, driven by increasing population at a risk of cardiovascular diseases.
December 12, 2022
Global Pacemakers Market Set to Grow at 5.4% CAGR Over Next 3 Years
December 12, 2022 —  The global pacemakers market is set to grow at a compound annual growth rate (CAGR) of 5.4%…
Read More
Michael A. Mussallem
December 12, 2022
Edwards Lifesciences Announces CEO Succession Plan
December 12, 2022 —  Edwards Lifesciences Corporation announced that following regular succession planning discussions…
Read More
US-based Weill Cornell Medicine has initiated a new clinical project together with the Mwanza International Trials Unit located in the Lake Zone of Tanzania with the aim of exploring the burden of arrhythmia in adults with and without HIV.
December 12, 2022
Weill Cornell Medicine partners with Poland-based company Cardiomatics to investigate the relationship between HIV and heart rhythm disorders
December 12, 2022 —  US-based Weill Cornell Medicine has initiated a new clinical project together with the Mwanza…
Read More
Clinical abstract focuses on value of PURE EP’s and its groundbreaking High Frequency Algorithm (HFA) during pulmonary vein isolation
December 09, 2022
BioSig’s PURE EP System Highlighted in the Journal of Atrial Fibrillation and Electrophysiology
December 9, 2022 —    BioSig Technologies, Inc.  an advanced digital signal processing technology company delivering…
Read More
Dr. Rami Kahwash, director of Ohio State’s Heart and Vascular Research Organization and a professor of clinical medicine in the Ohio State College of Medicine.
December 09, 2022
Ohio State First in World to Participate in Trial Confirming Efficacy of Novel Heart Failure Treatment
December 9, 2022 —  The Ohio State University Wexner Medical Center is first in the world to randomize a patient in a…
Read More
December 09, 2022
Ninerafaxstat Showcased at the 19th Annual Global Cardio Vascular Clinical Trialists (CVCT) Forum with Focus on the Potential in Non-obstructive Hypertrophic Cardiomyopathy
December 9, 2022 —  Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies…
Read More
Cardiac care should follow the patient on a virtual journey and deliver high-fidelity insights to care providers, eliminating the gaps in data transmission
December 08, 2022
With Minutes Between Life and Death, Continuous Remote ECG Monitoring Saves Lives
December 8, 2022 — Heart disease is the number one killer in the U.S., and high-fidelity monitoring is the beginning of…
Read More
Along with physician leaders and members, the society has helped the subspecialty officially join NRMP’s Medical Specialties Matching Program in 2025
December 08, 2022
SCAI Leads the Way for Interventional Cardiology to Join “The Match”
December 8, 2022 — The Society for Cardiovascular Angiography & Interventions (SCAI), a leading nonprofit medical…
Read More
Bempedoic acid becomes the first ATP citrate lyase inhibitor and first oral non-statin to meet the major adverse cardiovascular events (MACE-4) primary endpoint
December 08, 2022
Esperion Announces CLEAR Cardiovascular Outcomes Trial of NEXLETOL (bempedoic acid) Meets Primary Endpoint
December 8, 2022 — Esperion announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting …
Read More
Jonathan Rothberg, PhD
December 08, 2022
Butterfly Announces CEO Transition
December 8, 2022 — Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body…
Read More
Brian Arends, left, checks the electrical resistivity and conductivity of the wearable heart monitor as Zheng Yan, center, and Yadong Xu, right, observe in Yan's lab. The lab is located in the Roy Blunt NextGen Precision Health building. Pate McCuien/University of Missouri
December 07, 2022
University of Missouri Researchers Design New Heart Health Wearable
December 7, 2022 —  While heart disease is a leading cause of death in the United States, most people can be treated…
Read More
December 07, 2022
Computerized Decision Support System Helps to Reduce Cardiovascular Risk Factors in Patients with Diabetes
December 7, 2022 —  Compared with team-based care alone, the addition of a computerized clinical decision support…
Read More
Allogeneic CardiALLO therapy for heart failure to complement autologous cell therapy currently enrolling in Phase III CardiAMP Heart Failure clinical trial
December 07, 2022
BioCardia Announces FDA Approval of IND Application for Allogeneic NK1R+ Human Mesenchymal Stem Cells for Ischemic Heart Failure
December 7, 2022 —   BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of…
Read More
December 07, 2022
Ultromics Receives FDA Clearance for AI-based Platform for Echocardiography
December 7, 2022 — Ultromics has announced that its EchoGo Heart Failure, an artificial intelligence (AI) platform for…
Read More
Designed to assist physicians detect findings on chest X-rays suggestive of Aortic Atherosclerosis and Aortic Ectasia.
December 05, 2022
Imagen Technologies Announces FDA Clearance of Aorta-CAD
December 5, 2022 —  Imagen Technologies, Inc. announced the U.S. Food and Drug Administration's 510(k) clearance of the…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now